NIH Reporter #5R01HD112076-02

NIH-funded research on aspirin pharmacokinetics and pregnancy outcomes at Thomas Jefferson University

This opportunity involves a government-funded research project at Thomas Jefferson University, supported by the National Institutes of Health (NIH). - Government buyer: - Thomas Jefferson University, School of Medicine, Philadelphia, PA - Funded by NIH under CFDA Code 93.865 - Project scope: - Research on aspirin pharmacokinetics and pharmacodynamics in pregnancy - Randomized controlled trial targeting high-risk pregnancies - Focus on optimizing aspirin dosing and predicting pregnancy outcomes - Products/services requested: - No specific products, part numbers, or quantities listed - No equipment or service requirements detailed - OEMs and vendors: - No OEMs or vendors mentioned in the notice - Unique requirements: - Emphasis on developing predictive models for maternal and child health - Research aims to improve clinical outcomes through tailored aspirin therapy

Description

This project aims to determine how to optimally utilize aspirin during pregnancy to improve maternal and child health outcomes. It involves a randomized controlled trial with high-risk pregnancies, assessing aspirin response and pharmacokinetics. The study will develop models to predict outcomes and optimize dosing for pregnant patients. The research is conducted by Thomas Jefferson University and funded under CFDA Code 93.865 for Schools of Medicine.

View original listing